BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study)

Not yet recruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

November 1, 2024

Conditions
FertilizationFertilization in Vitro
Interventions
DRUG

recombinant hCG

"Experimental Group: Final oocyte triggering will be performed when the follicle or follicles measure between 13-16 mm.~Control Group: Final oocyte triggering will be performed when the follicle or follicles measure greater than 17 mm.~All triggers will be administered uniformly with 6500 units of recombinant hCG and 0,2 mg triptorelin injections.~The primary outcome of the study will be the number of mature oocytes. Secondary outcomes will include fertilization rates, embryo counts, and implantation rates.~Primary and secondary outcomes will be compared between the two groups."

All Listed Sponsors
lead

Centrum Clinic IVF Center

OTHER

NCT06433518 - BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study) | Biotech Hunter | Biotech Hunter